Skip to Main Content

When is a press release worth $5 billion? Can biotech stocks replace sports? And how will we know if a coronavirus vaccine actually works?

We discuss all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we break down the biggest news of the week: Moderna’s early-stage results from a coronavirus vaccine and the reaction from unsatisfied experts around the globe. Then, we examine how the world’s attention has turned to the biotech market, with volatile implications for every industry on the planet. Finally, we look back at the history of Moderna and the past controversies that set the stage for the company’s big moment.

For more on what we cover, here’s the news on Moderna’s vaccine data, and here’s the latest in STAT’s coronavirus coverage.


We’ll be back next Thursday evening — and every Thursday evening — so be sure to sign up on Apple PodcastsStitcherGoogle Play, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].


Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].